Maximum Dose of Meropenem
The maximum dose of meropenem is 2 grams every 8 hours (6 grams per day) for adults and 40 mg/kg every 8 hours (maximum 2 grams per dose) for pediatric patients 3 months and older. 1
Adult Dosing
According to FDA labeling, the standard maximum dosing for adults is:
- Standard infections (complicated skin/soft tissue): 500 mg-1 gram every 8 hours
- Complicated intra-abdominal infections: 1 gram every 8 hours
- Maximum approved dose: 2 grams every 8 hours (total 6 grams/day) 1
The 2 gram every 8 hours regimen is specifically indicated for bacterial meningitis in the FDA label 1. This represents the highest FDA-approved dose.
Higher Doses in Special Circumstances
While not FDA-approved, recent evidence suggests higher doses may be needed in specific clinical scenarios:
- Critically ill patients with augmented renal clearance: Up to 10.5 grams/day by continuous infusion may be required to achieve pharmacodynamic targets 2
- Severe burns: Doses up to 2 grams every 4 hours (12 grams/day) have been studied 3
- Multidrug-resistant organisms: Guidelines suggest standard dosing but emphasize continuous or extended infusions rather than higher total daily doses 4
Important caveat: These higher doses exceed FDA labeling and should only be considered with infectious disease consultation and therapeutic drug monitoring.
Pediatric Dosing
For children ≥3 months with normal renal function:
- Complicated skin/soft tissue: 10 mg/kg every 8 hours (max 500 mg/dose)
- Complicated intra-abdominal: 20 mg/kg every 8 hours (max 1 gram/dose)
- Meningitis: 40 mg/kg every 8 hours (max 2 grams/dose) 1
The absolute maximum is 2 grams per dose, regardless of weight. 1
For infants <3 months, dosing is weight and gestational age-based, with maximum individual doses of 30 mg/kg every 8 hours 1.
In cystic fibrosis children, 40 mg/kg every 8 hours (up to 2 grams) administered as prolonged 3-hour infusions has been studied and shown to improve target attainment 5.
Renal Impairment Adjustments
Critical point: Doses must be reduced in renal impairment 1:
- CrCl 26-50 mL/min: Standard dose every 12 hours
- CrCl 10-25 mL/min: Half dose every 12 hours
- CrCl <10 mL/min: Half dose every 24 hours
Administration Considerations
Extended or continuous infusions improve target attainment without increasing total daily dose 6, 2, 7:
- Standard infusion: 15-30 minutes
- Extended infusion: 3 hours (improves PK/PD for high MIC organisms)
- Continuous infusion: After loading dose (optimal for critically ill patients)
Recent data shows that even with aggressive dosing (loading dose followed by extended infusion), 38-45% of critically ill patients fail to achieve pharmacodynamic targets during the first dosing interval, particularly those with augmented renal clearance 7.
Common Pitfalls
Augmented renal clearance: Young, critically ill patients without apparent renal dysfunction may clear meropenem rapidly and require higher doses or therapeutic drug monitoring 2, 7
High MIC organisms: Standard dosing achieves targets only for MIC ≤2 mg/L; extended infusions are essential for MIC ≥4 mg/L 3
Meningitis dosing: The 2 gram every 8 hours dose is specifically for meningitis and should not be used routinely for other infections without justification 1
Seizure risk: While meropenem has a favorable CNS safety profile compared to imipenem, high doses still carry seizure risk, particularly in patients with CNS disorders or renal impairment 8